Evaluation of the diagnostic significance of the lymphocyte proliferation test in patients with Lyme borreliosis;Untersuchungen zur diagnostischen wertigkeit des lymphozytentransformationstestes bei patienten mit borreliose

LaboratoriumsMedizin

Volumn 31, Issue 3, 2007, Pages 149-158

  Von Baehr, Volker ^a   Liebenthal, Christa ^b   Gaida, Brita ^a   Schmidt, Frank Peter ^a   Von Baehr, Rüdiger ^a,c   Volk, Hans Dieter ^b  

^a Institut für Medizinische Diagnostik   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

^c Institut für Medizinische Diagnostik Berlin   (Germany)

Author keywords

Borreliosis; Diagnosis; Lymphocyte proliferation test; Serology

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL ANTIGEN; BACTERIUM ANTIBODY;

ANTIBIOTIC THERAPY; ANTIBODY DETECTION; ARTICLE; BACTERIUM CULTURE; BIOLOGICAL MONITORING; BORRELIA AFZELII; BORRELIA BURGDORFERI; BORRELIA GARINII; BORRELIA INFECTION; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE DURATION; EARLY DIAGNOSIS; ERYTHEMA CHRONICUM MIGRANS; FOLLOW UP; HUMAN; LYME DISEASE; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; REINFECTION; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SYMPTOMATOLOGY; VALIDATION PROCESS;

BORRELIA; BORRELIA AFZELII; BORRELIA BURGDORFERI; BORRELIA GARINII;

EID: 34250728683     PISSN: 03423026     EISSN: 14390477     Source Type: Journal    
DOI: 10.1515/JLM.2007.023     Document Type: Article

References (32)

1. Steere AC. Lyme disease. N Engl J Med 2001;345:115-25.
2. Tewald F, Braun R. Durchführung und Interpretation serologischer Tests bei Verdacht auf Borrelieninfektion. Clin Lab 1998;44:897-902.
3. Dejmkova H, Hulinska D, Tegzova D, Pavelka K, Gatterova J, Vavrik P. Seronegative Lyme arthritis caused bei Borrelia garinii. Clin Rheumatol 2002;21:330-4.
4. Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP. Diagnosis of Lyme borreliosis. Clin Microbiol Rev 2005;18:484-509.
5. Wilske B, Fingerle V. Lyme-Borreliose Diagnostik. Mikrobiologe 2005;15:209-20.
6. Kalish RA, McHugh G, Granquist J, Shea B, Ruthazer R, Steere AC. Persistence of immunoglobulin M or G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease. Clin Infect Dis 2001;33:780-5.
7. Schütt C. Lymphozytentransformationstest (LTT). In: Friemel H, editor. Immunologische Arbeitsmethoden. G Fischer Verlag Jena 1991:349-55.
8. Sigal LH, Moffat CM, Steere AC, Dwyer JM. Cellular immune findings in Lyme disease. Yale J Biol Med 1984;57:595-8.
9. Sigal LH, Steere AC, Freeman DH, Dwyer JM. Proliferative responses of mononuclear cells in Lyme disease. Reactivity to Borrelia burgdorferi antigens is greater in joint fluid than in blood. Arthritis Rheum 1986;29:761-9.
10. Dattwyler RJ, Volkman DJ, Luft BJ, Halperin JJ, Thomas J, Golightly MG. Seronegative Lyme disease. Dissociation of specific T- and B-lymphocyte responses to Borrelia burgdorferi. N Engl J Med 1988;319:1441-6.
11. Dressler F, Yoshinari NH, Steere AC. The T-cell proliferative assay in the diagnosis of Lyme disease. Ann Intern Med 1991;115:533-9.
12. Krause A, Brade V, Schoerner C, Solbach W, Kalden JR, Burmester GR. T cellproliferation induced by Borrelia burgdorferi in patients with Lyme borreliosis. Autologous serum required for optimum stimulation. Arthritis Rheum 1991;34:393-402.
13. Schempp C, Owsianoski M, Lange R, Gollnick H. Comparison of Borrelia burgdorferi ultrasonicate and whole B. burgdorferi cells as a stimulus for T-cell proliferation and GM-CSF secretion in vitro. Zentralbl Bakteriol 1993;279:417-25.
14. Schempp C, Bocklage H, Owsianowski M, Lange R, Orfanos CE, Gollnick H. In vivo und in vitro Nachweis einer Borrelieninfektion bei einer morpheaähnlichen Hautveränderung mit negativer Borrelienserologie. Hautarzt 1993;44:14-8.
15. Buechner SA, Lautenschläger S, Itin P, Bircher A, Erb P. Lymphoproliferative responses to Borrelia burgdorferi in patients with erythema migrans, acrodermatitis chronica atrophicans, lymphadenosis benigna cutis, and morphea. Arch Dermatol 1995;131:673-7.
16. Breier F, Klade H, Stanek G, Poitschek C, Kirnbauer R, Dorda W, et al. Lymphoproliferative responses to Borrelia burgdorferi in circumscribed scleroderma. J Dermatol 1996;134:285-91.
17. Rutkowski S, Busch DH, Huppertz HI. Lymphocyte proliferation assay in response to Borrelia burgdorferi in patients with Lyme arthritis: analysis of lymphocyte subsets. Rheumatol Int 1997;17:151-8.
18. Zoschke DC, Skemp AA, Defosse DL. Lymphoproliferative responses to Borrelia burgdorferi in Lyme disease. Ann Intern Med 1991;114:285-9.
19. Roessner K, Fikrig E, Russel JQ, Cooper SM, Flavell RA, Budd RC. Prominent T lymphocyte response to Borrelia burgdorferi from peripheral blood of unexposed donors. Eur J Immunol 1994;24:320-4.
20. Huppertz HI, Mösbauer S, Busch DH, Karch H. Lymphoproliferative responses to Borrelia burgdorferi in the diagnosis of Lyme arthritis in children and adolescents. Eur J Pediatr 1996;155:297-302.
21. Breier F, Klade H, Stanek G. Lymphoproliferationstest bei kutanen Manifestationen der Lyme-Borreliose. Wien Med Wschr 1995;145:170-3.
22. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Cin Lab Invest Suppl 1968;97:77-89.
23. von Baehr V, Mayer W, Liebenthal C, von Baehr R, Bieger W, Volk HD. Improving the in vitro antigen specific T cell proliferation assay: the use of interferon-alpha to elicit anti gen specific stimulation and decrease bystander proliferation. J Immunol Methods 2001;251:63-71.
24. Horowitz HH, Pavia CS, Bittker S, Forseter G, Cooper D, Nadelman RB, et al. Sustained cellular immune responses to Borrelia burgdorferi: lack of correlation with clinical presentation and serology. Clin Diagn Lab Immunol 1994;1:373-8.
25. Pohl-Koppe A, Kaunicnik A, Wilske B. Characterization of the cellular and humoral immune response to outer surface protein C and outer surface protein 17 in children with early disseminated Lyme borreliosis. Med Microbiol Immunol 2001;189:193-200.
26. Vaz A, Glickstein L, Field JA, McHugh G, Sikand VK, Damle N, et al. Cellular and humoral immune responses to Borrelia burgdorferi antigens in patients with culture-positive early Lyme disease. Infect Immun 2001;69:7437-44.
27. Priem S, Burmester GR, Kamradt T, Wolbart K, Rittig MG, Krause A. Detection of Borrelia burgdorferi by polymerase chain reaction in synovial membrane, but not synovial fluid from patients with persisting Lyme arthritis after antibiotic therapy. Ann Rheum Dis 1998;57:118-21.
28. Phillips SE, Mattman LH, Hulinska D, Moayad H. A proposal for the reliable culture of Borrelia burgdorferi from patients with chronic Lyme disease, even from those previously aggressively treated. Infektion 1998;26:364-7.
29. Oksi J, Marjamaki M, Nikoskelainen J, Viljanen MK. Borrelia burgdorferi detected by culture and PCR in clinical relapse of disseminated Lyme borreliosis. Ann Med 1999;31:225-32.
30. Honegr K, Hulinska D, Beran J, Dostal V, Havlasova J, Cermakova Z. Long-term and repeated electron microscopy and PCR detection of Borrelia burgdorferi sensu lato after an antibiotic treatment. Cent Eur J Public Health 2004;12:6-11.
31. Schröder NW, Diterich I, Zinke A, Eckert J, Draing C, von Baehr V, et al. Heterozygous Arg753Gln polymorphism of human TLR-2 impairs immune activation by Borrelia burgdorferi and protects from late stage Lyme disease. J Immunol 2005;175:2534-40.
32. Valentine-Thon E, Ilsemann K, Sandkamp M. A novel lymphocyte transformation test (LTT-MELISA(R)) for Lyme borreliosis. Diagn Microbiol Infect Dis 2007;57:27-34.